Yoshida Kiyohito, Yoshimatsu Kazuhiko, Otani Taisuke, Yokomizo Hajime, Ogawa Kenji
Department of Surgery, Tokyo Women's Medical University Medical Center East, Arakawa-ku, Tokyo 116-8567, Japan.
Anticancer Res. 2008 May-Jun;28(3B):1773-8.
The distance of tumor invasion beyond the outer border of the muscularis propria (DBM) was measured whether it would be useful as a prognostic factor of the locally advanced rectal and rectosigmoid cancer was analyzed.
One hundred patients with rectal and rectosigmoid cancer invaded beyond muscularis propria who underwent surgery between 1996 and 2000 were included in this study. Patients who died due to other disease were excluded. Univariate and multivariate analyses of the risk factors including DBM for disease-free and cancer-related survival after surgery were performed.
The median DBM was 4,000 microm and patients were thus classified into 2 groups by DBM (<4,000 microm and > or =4,000 microm). In univariate analysis, patients with a DBM of > or =4000 microm had a significantly poorer prognosis both for cancer-related survival (CRS) (p=0.004) and disease-free survival (DFS) (p=0.0025). Within many prognostic factors, lymphatic invasion (p=0.025), venous invasion (p=0.0402) and pattern of tumor infiltration (p=0.043) significantly correlated with DBM. In multivariate analysis with other factors including histology (p=0.0403), node status (p=0.0003), lymphatic invasion (p=0.0004), venous invasion (p<0.0001), tumor budding (p=0.0343) and pattern of tumor infiltration (p=0.0160), DBM was selected as the most significant prognostic factor for both CRS (hazard ratio (HR): 2.1682, 95% confidence interval (CI): 1.3606-3.8097, p=0.0019) and DFS (HR: 2.0654, 95% CI: 1.2696-3.8257, p=0.0075).
Since DBM was the most significant prognostic factor, it could be used to categorize T-factor in clinical staging of advanced rectal and rectosigmoid cancer.
测量肿瘤侵犯超过固有肌层外边界的距离(DBM),分析其是否可作为局部进展期直肠癌和直肠乙状结肠癌的预后因素。
本研究纳入了1996年至2000年间接受手术的100例固有肌层外侵犯的直肠癌和直肠乙状结肠癌患者。排除因其他疾病死亡的患者。对包括DBM在内的术后无病生存和癌症相关生存的危险因素进行单因素和多因素分析。
DBM中位数为4000微米,因此患者按DBM分为两组(<4000微米和≥4000微米)。单因素分析中,DBM≥4000微米的患者在癌症相关生存(CRS)(p = 0.004)和无病生存(DFS)(p = 0.0025)方面预后均显著较差。在众多预后因素中,淋巴血管浸润(p = 0.025)、静脉浸润(p = 0.0402)和肿瘤浸润模式(p = 0.043)与DBM显著相关。在包括组织学(p = 0.0403)、淋巴结状态(p = 0.0003)、淋巴血管浸润(p = 0.0004)、静脉浸润(p < 0.0001)、肿瘤芽生(p = 0.0343)和肿瘤浸润模式(p = 0.0160)等其他因素的多因素分析中,DBM被选为CRS(风险比(HR):2.1682,95%置信区间(CI):1.3606 - 3.8097,p = 0.0019)和DFS(HR:2.0654,95%CI:1.2696 - 3.8257,p = 0.0075)最显著的预后因素。
由于DBM是最显著的预后因素,它可用于晚期直肠癌和直肠乙状结肠癌临床分期中T分期的分类。